297 related articles for article (PubMed ID: 20833746)
21. Hepatitis C virus RNA: dinucleotide frequencies and cleavage by RNase L.
Washenberger CL; Han JQ; Kechris KJ; Jha BK; Silverman RH; Barton DJ
Virus Res; 2007 Dec; 130(1-2):85-95. PubMed ID: 17604869
[TBL] [Abstract][Full Text] [Related]
22. RIG-I detects viral genomic RNA during negative-strand RNA virus infection.
Rehwinkel J; Tan CP; Goubau D; Schulz O; Pichlmair A; Bier K; Robb N; Vreede F; Barclay W; Fodor E; Reis e Sousa C
Cell; 2010 Feb; 140(3):397-408. PubMed ID: 20144762
[TBL] [Abstract][Full Text] [Related]
23. Identification of a Natural Viral RNA Motif That Optimizes Sensing of Viral RNA by RIG-I.
Xu J; Mercado-López X; Grier JT; Kim WK; Chun LF; Irvine EB; Del Toro Duany Y; Kell A; Hur S; Gale M; Raj A; López CB
mBio; 2015 Oct; 6(5):e01265-15. PubMed ID: 26443454
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis C virus NS5B triggers an MDA5-mediated innate immune response by producing dsRNA without the replication of viral genomes.
Dansako H; Ikeda M; Ariumi Y; Togashi Y; Kato N
FEBS J; 2024 Mar; 291(6):1119-1130. PubMed ID: 37863517
[TBL] [Abstract][Full Text] [Related]
25. (-)-Epigallocatechin-3-Gallate Enhances Hepatitis C Virus Double-Stranded RNA Intermediates-Triggered Innate Immune Responses in Hepatocytes.
Wang Y; Li J; Wang X; Peña JC; Li K; Zhang T; Ho W
Sci Rep; 2016 Feb; 6():21595. PubMed ID: 26879672
[TBL] [Abstract][Full Text] [Related]
26. Hepatitis C Virus Infection Is Inhibited by a Noncanonical Antiviral Signaling Pathway Targeted by NS3-NS4A.
Vazquez C; Tan CY; Horner SM
J Virol; 2019 Dec; 93(23):. PubMed ID: 31534039
[TBL] [Abstract][Full Text] [Related]
27. Genomic HIV RNA induces innate immune responses through RIG-I-dependent sensing of secondary-structured RNA.
Berg RK; Melchjorsen J; Rintahaka J; Diget E; Søby S; Horan KA; Gorelick RJ; Matikainen S; Larsen CS; Ostergaard L; Paludan SR; Mogensen TH
PLoS One; 2012; 7(1):e29291. PubMed ID: 22235281
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of RIG-I-dependent signaling to the interferon pathway during hepatitis C virus expression and restoration of signaling by IKKepsilon.
Breiman A; Grandvaux N; Lin R; Ottone C; Akira S; Yoneyama M; Fujita T; Hiscott J; Meurs EF
J Virol; 2005 Apr; 79(7):3969-78. PubMed ID: 15767399
[TBL] [Abstract][Full Text] [Related]
29. Rotavirus Controls Activation of the 2'-5'-Oligoadenylate Synthetase/RNase L Pathway Using at Least Two Distinct Mechanisms.
Sánchez-Tacuba L; Rojas M; Arias CF; López S
J Virol; 2015 Dec; 89(23):12145-53. PubMed ID: 26401041
[TBL] [Abstract][Full Text] [Related]
30. Sensitivity of hepatitis C virus RNA to the antiviral enzyme ribonuclease L is determined by a subset of efficient cleavage sites.
Han JQ; Wroblewski G; Xu Z; Silverman RH; Barton DJ
J Interferon Cytokine Res; 2004 Nov; 24(11):664-76. PubMed ID: 15684820
[TBL] [Abstract][Full Text] [Related]
31. Activation of RNase L in Egyptian Rousette Bat-Derived RoNi/7 Cells Is Dependent Primarily on OAS3 and Independent of MAVS Signaling.
Li Y; Dong B; Wei Z; Silverman RH; Weiss SR
mBio; 2019 Nov; 10(6):. PubMed ID: 31719180
[TBL] [Abstract][Full Text] [Related]
32. [RIG-I mediated hepatic innate immune signaling that controls HCV infection].
Saito T; Gale M
Uirusu; 2008 Dec; 58(2):105-15. PubMed ID: 19374189
[TBL] [Abstract][Full Text] [Related]
33. Characterization of HCV interactions with Toll-like receptors and RIG-I in liver cells.
Eksioglu EA; Zhu H; Bayouth L; Bess J; Liu HY; Nelson DR; Liu C
PLoS One; 2011; 6(6):e21186. PubMed ID: 21695051
[TBL] [Abstract][Full Text] [Related]
34. Ribonuclease L and metal-ion-independent endoribonuclease cleavage sites in host and viral RNAs.
Cooper DA; Jha BK; Silverman RH; Hesselberth JR; Barton DJ
Nucleic Acids Res; 2014 Apr; 42(8):5202-16. PubMed ID: 24500209
[TBL] [Abstract][Full Text] [Related]
35. Innate host response in primary human hepatocytes with hepatitis C virus infection.
Yang D; Liu N; Zuo C; Lei S; Wu X; Zhou F; Liu C; Zhu H
PLoS One; 2011; 6(11):e27552. PubMed ID: 22087337
[TBL] [Abstract][Full Text] [Related]
36. The C-terminal regulatory domain is the RNA 5'-triphosphate sensor of RIG-I.
Cui S; Eisenächer K; Kirchhofer A; Brzózka K; Lammens A; Lammens K; Fujita T; Conzelmann KK; Krug A; Hopfner KP
Mol Cell; 2008 Feb; 29(2):169-79. PubMed ID: 18243112
[TBL] [Abstract][Full Text] [Related]
37. [Innate immune responses against viral infection and its suppression by viral proteins].
Oshiumi H; Matsumoto M; Seya T
Yakugaku Zasshi; 2013; 133(3):323-8. PubMed ID: 23449408
[TBL] [Abstract][Full Text] [Related]
38. Antiviral immunity via RIG-I-mediated recognition of RNA bearing 5'-diphosphates.
Goubau D; Schlee M; Deddouche S; Pruijssers AJ; Zillinger T; Goldeck M; Schuberth C; Van der Veen AG; Fujimura T; Rehwinkel J; Iskarpatyoti JA; Barchet W; Ludwig J; Dermody TS; Hartmann G; Reis e Sousa C
Nature; 2014 Oct; 514(7522):372-375. PubMed ID: 25119032
[TBL] [Abstract][Full Text] [Related]
39. Detection of tRNA-like structure through RNase P cleavage of viral internal ribosome entry site RNAs near the AUG start triplet.
Lyons AJ; Robertson HD
J Biol Chem; 2003 Jul; 278(29):26844-50. PubMed ID: 12746454
[TBL] [Abstract][Full Text] [Related]
40. RNase L targets distinct sites in influenza A virus RNAs.
Cooper DA; Banerjee S; Chakrabarti A; García-Sastre A; Hesselberth JR; Silverman RH; Barton DJ
J Virol; 2015 Mar; 89(5):2764-76. PubMed ID: 25540362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
